India approves Sputnik V vaccine against Covid-19, to produce 850 million doses annually: RDIF
NEW DELHI: The Russian Direct Investment Fund (RDIF) has said that India has become the 60th country to approve the...
Coronavirus
Expert panel recommends granting approval to Covid-19 vaccine Sputnik V for emergency use in India
NEW DELHI: An expert panel of India''s central drug authority has recommended granting approval to Russian COVID-19 vaccine Sputnik V...
Covid-19: Gujarat heading towards health emergency, says High Court
GANDHINAGAR: Taking a serious note of the worsening coronavirus situation, especially on the healthcare system and infrastructure, the Gujarat High...
‘Tika Utsav’ beginning of second big war on coronavirus, says Narendra Modi
NEW DELHI: Asserting that the 'Tika Utsav', a vaccination drive between April 11 and 14, marks the beginning of the...
India is the fastest country to administer 100 million doses of Covid-19 vaccine
NEW DELHI: India is the fastest country in the world to administer 100 million doses of Covid-19 vaccine. India achieved...
Oxford-AstraZeneca Covid-19 vaccine: WHO rejects Serum Institute of India’s proposal for extension of Covishield’s shelf life
NEW DELHI: The WHO has rejected Serum Institute of India's proposal seeking extension of the shelf life of Oxford-AstraZeneca COVID-19...
Pakistan approves third Chinese Covid-19 vaccine despite low efficacy
NEW DELHI: Pakistan has approved the emergency use of the third Chinese Covid-19 vaccine, despite its low efficacy rate, as...
Covid-19 vaccine supply abroad to continue after domestic requirement: India
NEW DELHI: Asserting that India has not imposed any export ban on anti-coronavirus vaccines, the Ministry of External Affairs (MEA)...
AstraZeneca legal notice to Serum Institute over delays in supplying Covid-19 vaccine
NEW DELHI: Adar Poonawalla's Serum Institute of India (SII) has been served a legal notice by AstraZeneca over delays in...
Serum Institute of India require around Rs 3,000 crore to ramp up vaccine production: Adar Poonawalla
NEW DELHI: Serum Institute of India (SII) would require around Rs 3,000 crore to ramp up production capacity for making...
